Skip to main content
Livermore
Livermore
ZHEN

UroGen Pharma Ltd.

URGN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001668243

In the last 90 days, UroGen Pharma Ltd. insiders filed 0 open-market purchases and 4 sales; 190 institutions reported holding it in 13F filings for Q2 2026, worth $1.56B in total; ARK Invest is the only superinvestor holding it.

Holders of 5% or more of URGN

Holders whose latest Schedule 13D or 13G filing reports 5% or more of UroGen Pharma Ltd., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of URGN
HolderLatest formStakeChangeFirst filedLatest filingFiling
Toronto Dominion Bank13G/A6.70%3.27M shares+1.30 ppfrom 5.40%Nov 14, 20254 filingsAug 12, 2026SEC
Morgan Stanley13G5.40%2.49M shares+3.60 ppfrom 1.80%Feb 5, 20252 filingsAug 6, 2025SEC
BlackRock, Inc.13G5.20%2.52M shares+0.20 ppfrom 5.00%Jul 16, 20252 filingsApr 27, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

47 Schedule 13D and 13G filings on UroGen Pharma Ltd., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on URGN
Filed (ET)FilerFormStakeChangeEvent dateFiling
Aug 12, 20264:10 PM ETToronto Dominion Bankand 1 other13G/A6.70%3.27M shares+1.30 ppfrom 5.40%Jun 30, 2026SEC
May 15, 20264:25 PM ETParadigm Biocapital Advisors LPand 3 others13G/A3.50%1.70M shares−5.50 ppfrom 9.00%Below 5%Mar 31, 2026SEC
May 15, 20261:46 PM ETToronto Dominion Bankand 1 other13G5.40%2.62M shares+0.50 ppfrom 4.90%Mar 31, 2026SEC
Apr 27, 20264:12 PM ETBlackRock, Inc.13G5.20%2.52M shares+0.20 ppfrom 5.00%Mar 31, 2026SEC
Feb 13, 20261:04 PM ETToronto Dominion Bank13G/A4.90%2.30M shares−2.00 ppfrom 6.90%Below 5%Dec 31, 2025SEC
Nov 14, 20254:31 PM ETParadigm Biocapital Advisors LPand 3 others13G/A9.00%4.22M shares+4.00 ppfrom 5.00%Sep 30, 2025SEC
Nov 14, 202511:26 AM ETToronto Dominion Bank13G6.90%3.19M sharesNewSep 30, 2025SEC
Nov 14, 202511:26 AM ETCowen Financial Products LLC13G/A0.00%0 shares−6.90 ppfrom 6.90%Below 5%Sep 30, 2025SEC
Aug 14, 20256:13 PM ETRa Capital Management, L.P.and 3 others13G/A0.00%0 shares−7.00 ppfrom 7.00%Below 5%Jun 30, 2025SEC
Aug 12, 20254:30 PM ETParadigm Biocapital Advisors LPand 3 others13G5.00%2.33M sharesNewAug 5, 2025SEC
Aug 6, 20253:56 PM ETMorgan Stanley13G5.40%2.49M shares+3.60 ppfrom 1.80%Jun 30, 2025SEC
Aug 5, 20255:00 PM ETSoleus Capital Master Fund, L.P.and 5 others13G/A4.70%2.19M shares−0.30 ppfrom 5.00%Below 5%Jun 30, 2025SEC
Jul 29, 20254:56 PM ETCowen Financial Products LLC13G/A6.90%3.19M shares+1.10 ppfrom 5.80%Jun 30, 2025SEC
Jul 16, 20257:02 PM ETBlackRock, Inc.13G/A5.00%2.28M shares–Jun 30, 2025SEC
Jun 16, 20255:00 PM ETSoleus Capital Master Fund, L.P.and 5 others13G5.00%2.33M sharesNewJun 13, 2025SEC
Jun 13, 202511:38 AM ETCowen Financial Products LLC13G5.80%2.65M sharesNewJun 9, 2025SEC
Jun 9, 20257:19 PM ETMonograph Capital Holdings Advisors, LLCand 4 others13D/A1.90%838.6K shares–Below 5%Jun 5, 2025SEC
May 15, 20254:53 PM ETRa Capital Management, L.P.and 3 others13G/A7.00%3.21M shares–Mar 31, 2025SEC
May 12, 20259:02 AM ETAdage Capital Management, L.P.and 2 others13G/A2.77%1.28M shares−4.17 ppfrom 6.94%Below 5%Mar 31, 2025SEC
Mar 17, 20251:23 PM ETMenora Mivtachim Holdings Ltd.13G/A4.99%2.30M shares–Below 5%Mar 11, 2025SEC
Feb 12, 20259:34 AM ETAdage Capital Management, L.P.and 2 others13G/A6.94%2.93M shares–Dec 31, 2024SEC
Feb 5, 202510:09 AM ETMorgan Stanley13G/A1.80%752.9K shares–Below 5%Dec 31, 2024SEC
Jun 24, 2024Cowen and Company, LLC13GOld format–New–SEC
Jun 24, 2024Point72 Asset Management, L.P.13GOld format–New–SEC
Feb 22, 2024Arkin Moshe13D/AOld format–––SEC
Feb 14, 2024Menora Mivtachim Holdings Ltd.13G/AOld format–––SEC
Feb 14, 2024Great Point Partners LLC13G/AOld format–––SEC
Feb 14, 2024Ra Capital Management, L.P.13G/AOld format–––SEC
Feb 14, 2024RTW Investments, LP13GOld format–New–SEC
Feb 13, 2024Stonepine Capital Management, LLC13G/AOld format–––SEC
Feb 2, 20242:18 PM ETBlackRock Inc.13GOld format–––SEC
Dec 29, 2023Ra Capital Management, L.P.13GOld format–New–SEC
Sep 15, 2023Great Point Partners LLC13GOld format–New–SEC
Aug 4, 2023Monograph Capital Holdings Advisors, LLC13DOld format–New–SEC
Jun 12, 2023Menora Mivtachim Holdings Ltd.13G/AOld format–––SEC
Feb 13, 2023Stonepine Capital Management, LLC13G/AOld format–––SEC
Dec 1, 2022Stonepine Capital Management, LLC13GOld format–New–SEC
Jul 8, 20224:57 PM ETBlackRock Inc.13GOld format–––SEC
Feb 14, 2022Credit Suisse AG13G/AOld format–––SEC
Feb 14, 2022Wildcat Capital Management, LLC13G/AOld format–––SEC
Feb 4, 2022Wellington Management Group LLP13G/AOld format–––SEC
Feb 3, 20224:41 PM ETBlackRock Inc.13G/AOld format–––SEC
Feb 12, 2021Credit Suisse AG13GOld format–New–SEC
Feb 12, 2021Wildcat Capital Management, LLC13G/AOld format–––SEC
Feb 11, 2021Menora Mivtachim Holdings Ltd.13G/AOld format–––SEC
Feb 3, 2021Wellington Management Group LLP13G/AOld format–––SEC
Feb 1, 20218:17 AM ETBlackRock Inc.13G/AOld format–––SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell UroGen Pharma Ltd. shares.

No Form 144 notices for UroGen Pharma Ltd. are on file.